Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Harding, MD
Memorial Sloan-Kettering Cancer Center (MSKCC)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Chinese People'S Liberation Army 81 Hospital
Nanjing, Jiangsu, China
- West China Hospital, Sichuan University
Chengdu, Sichuan, China
- Irccs Ca Granda Ospedale Maggiore Policlinico
Milan, Lombardy, Italy
- National Cancer Institute of Napoli Irccs G. Pascale
Naples, Italy
- Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
- Pusan National University Hospital
Busan, South Korea
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- the Catholic University of Korea, Seoul St. Mary'S Hospital
Seoul, South Korea
- Changhua Christian Hospital
Changhua, Taiwan
- Chang Gung Medical Foundation - Kaohsiung
Kaohsiung City, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
- Chi Mei Hospital, Liouying
Tainan, Taiwan
- Chi Mei Medical Center
Tainan, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- Mackay Memorial Hospital
Taipei, Taiwan
- Taipei Medical University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Tri-Service General Hospital
Taipei, Taiwan
- Chang Gung Medical Foundation - Linkou
Taoyuan, Taiwan
- the Clatterbridge Cancer Centre Nhs Foundation Trust
Bebington, Wirral, United Kingdom
- Guy'S & St Thomas' Nhs Foundation Trust
London, United Kingdom
- Royal Free Hospital
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- California Pacific Medical Center
San Francisco, California, United States
- Emory University
Atlanta, Georgia, United States
- the University of Chicago Medical Center
Chicago, Illinois, United States
- the University of Kansas Cancer Center
Westwood, Kansas, United States
- Masonic Cancer Center
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2014
- Primary completion
- 29 Feb 2020
- Completion
- 29 Feb 2020
- Last update posted
- 25 Apr 2022
- Registered enrollment
- 140
- Registry id
- NCT02102022
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.